Press releases
- Bayer and Hologic Collaborating to Deliver Contrast-Enhanced Mammography
- Hologic to Announce Financial Results for the Second Quarter of Fiscal 2024 on Thursday, May 2, 2024
- Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be Over- or Undertreated Without Breast Cancer Index Genomic Testing
- Hologic to Unveil Groundbreaking AI Research at ECR 2024
- Hologic to Webcast Presentations at Upcoming Investor Conferences
- Hologic Announces First and Only FDA-Cleared Digital Cytology System – Genius™ Digital Diagnostics System
- Hologic Announces Financial Results for First Quarter of Fiscal 2024
More ▼
Key statistics
On Tuesday, Hologic Inc (0J5Q:LSE) closed at 77.01, -11.02% below its 52-week high of 86.55, set on May 09, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 77.01 |
Average volume | 5.46k |
---|---|
Shares outstanding | 234.73m |
Free float | 232.98m |
P/E (TTM) | 36.24 |
Market cap | 17.89bn USD |
EPS (TTM) | 2.10 USD |
Data delayed at least 20 minutes, as of Apr 23 2024 17:22 BST.
More ▼